ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 156 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2017. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $433 | +279.8% | 12,156 | +390.4% | 0.01% | +400.0% |
Q2 2023 | $114 | -88.4% | 2,479 | -89.9% | 0.00% | -90.9% |
Q1 2023 | $982 | -11.1% | 24,486 | +2.8% | 0.01% | -15.4% |
Q4 2022 | $1,104 | -99.9% | 23,827 | -31.5% | 0.01% | -27.8% |
Q3 2022 | $1,441,000 | +12.3% | 34,803 | +61.8% | 0.02% | +28.6% |
Q2 2022 | $1,283,000 | -5.0% | 21,507 | +15.6% | 0.01% | +40.0% |
Q1 2022 | $1,351,000 | +788.8% | 18,602 | +928.3% | 0.01% | +900.0% |
Q4 2021 | $152,000 | -15.6% | 1,809 | -9.3% | 0.00% | 0.0% |
Q3 2021 | $180,000 | -98.6% | 1,994 | -98.5% | 0.00% | -98.4% |
Q2 2021 | $13,071,000 | +762.2% | 137,084 | +929.4% | 0.06% | +662.5% |
Q1 2021 | $1,516,000 | +239.1% | 13,317 | +312.3% | 0.01% | +300.0% |
Q4 2020 | $447,000 | +29.9% | 3,230 | -22.7% | 0.00% | 0.0% |
Q3 2020 | $344,000 | +9.6% | 4,181 | +4.1% | 0.00% | -33.3% |
Q2 2020 | $314,000 | -45.7% | 4,017 | -69.1% | 0.00% | -40.0% |
Q1 2020 | $578,000 | -10.7% | 12,998 | -14.2% | 0.01% | -16.7% |
Q4 2019 | $647,000 | -22.3% | 15,151 | -22.1% | 0.01% | -14.3% |
Q3 2019 | $833,000 | +91.9% | 19,461 | +184.8% | 0.01% | +133.3% |
Q2 2019 | $434,000 | -96.5% | 6,834 | -96.2% | 0.00% | -97.4% |
Q1 2019 | $12,571,000 | +4488.0% | 181,237 | +2775.4% | 0.12% | +5700.0% |
Q4 2018 | $274,000 | +138.3% | 6,303 | +320.2% | 0.00% | +100.0% |
Q3 2018 | $115,000 | -46.3% | 1,500 | -46.1% | 0.00% | -50.0% |
Q2 2018 | $214,000 | +22.3% | 2,783 | -19.0% | 0.00% | +100.0% |
Q1 2018 | $175,000 | +20.7% | 3,435 | +10.1% | 0.00% | 0.0% |
Q4 2017 | $145,000 | -7.1% | 3,120 | +6.5% | 0.00% | 0.0% |
Q3 2017 | $156,000 | -82.3% | 2,929 | -76.6% | 0.00% | -85.7% |
Q4 2016 | $880,000 | +12.5% | 12,520 | +13.6% | 0.01% | -12.5% |
Q3 2016 | $782,000 | +106.3% | 11,021 | +84.0% | 0.01% | +166.7% |
Q1 2016 | $379,000 | -11.9% | 5,990 | +34.3% | 0.00% | 0.0% |
Q3 2015 | $430,000 | +194.5% | 4,461 | +213.3% | 0.00% | +200.0% |
Q2 2015 | $146,000 | -40.7% | 1,424 | -64.1% | 0.00% | 0.0% |
Q1 2015 | $246,000 | +22.4% | 3,969 | -13.3% | 0.00% | 0.0% |
Q4 2014 | $201,000 | +45.7% | 4,579 | +88.4% | 0.00% | 0.0% |
Q3 2014 | $138,000 | – | 2,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |